文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

纳米疫苗及其作用模式。

Nanovaccines and their mode of action.

机构信息

School of Chemistry and Molecular Biosciences (SCMB), The University of Queensland, St. Lucia 4072, Queensland, Australia.

出版信息

Methods. 2013 May 1;60(3):226-31. doi: 10.1016/j.ymeth.2013.04.014. Epub 2013 Apr 24.


DOI:10.1016/j.ymeth.2013.04.014
PMID:23623821
Abstract

Nanosized particles including nanovaccines are a novel approach to the development of vaccines to combat diseases. Nanovaccines have the promise to utilize the immune system to cure infections and to prevent infections and diseases from spreading. Rational vaccine development requires an understanding of vaccine mediated stimulation of the immune system. We review here immunostimulatory properties of nanovaccines including their immunogenicity, adjuvant properties, inflammatory responses and the mechanisms of uptake and stimulation of immune cells. Examples of various nanoparticles currently being developed as vaccines are also provided.

摘要

纳米颗粒包括纳米疫苗,是开发用于对抗疾病的疫苗的一种新方法。纳米疫苗有望利用免疫系统来治愈感染,并防止感染和疾病的传播。合理的疫苗开发需要了解疫苗对免疫系统的刺激作用。我们在这里回顾了纳米疫苗的免疫刺激特性,包括它们的免疫原性、佐剂特性、炎症反应以及免疫细胞摄取和刺激的机制。还提供了目前正在开发为疫苗的各种纳米粒子的例子。

相似文献

[1]
Nanovaccines and their mode of action.

Methods. 2013-4-24

[2]
The impact of size on particulate vaccine adjuvants.

Nanomedicine (Lond). 2014-12

[3]
Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers.

Methods. 2013-5-1

[4]
Dendrimers for vaccine and immunostimulatory uses. A review.

Bioconjug Chem. 2010-3-17

[5]
Recent advances in peptide-based subunit nanovaccines.

Nanomedicine (Lond). 2014-12

[6]
Utilizing bacterial flagellins against infectious diseases and cancers.

Antonie Van Leeuwenhoek. 2014-2

[7]
The immunological adjuvant and vaccine carrier properties of liposomes.

J Drug Target. 1994

[8]
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.

Vaccine. 2010-4-21

[9]
A mini review for lipid-based nanovaccines: from their design to their applications.

J Liposome Res. 2023-9

[10]
A Glance on Nanovaccine: A Potential Approach for Disease Prevention.

Curr Pharm Biotechnol. 2024

引用本文的文献

[1]
Revolutionizing Nanovaccines: A New Era of Immunization.

Vaccines (Basel). 2025-1-27

[2]
Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review.

Vaccines (Basel). 2024-11-27

[3]
Functionally Designed Nanovaccines against SARS-CoV-2 and Its Variants.

Vaccines (Basel). 2024-7-12

[4]
Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish.

World J Microbiol Biotechnol. 2024-6-24

[5]
Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment.

ACS Omega. 2023-11-1

[6]
A Glance on Nanovaccine: A Potential Approach for Disease Prevention.

Curr Pharm Biotechnol. 2024

[7]
Nano- and Microemulsions in Biomedicine: From Theory to Practice.

Pharmaceutics. 2023-7-20

[8]
Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.

Hum Vaccin Immunother. 2022-11-30

[9]
Antiviral potential of nanoparticles for the treatment of Coronavirus infections.

J Trace Elem Med Biol. 2022-7

[10]
Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.

Antimicrob Agents Chemother. 2022-4-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索